Peng‐Hui Wang
Biographic Data
| ID | 7858459 |
|---|---|
| NAME | Peng‐Hui Wang |
| GIVEN NAMES | Peng‐Hui |
| FAMILY NAME | Wang |
| SIGNATURE | WANG P H |
| AFFILIATIONS | National Yang Ming Chiao Tung University |
| ORCID | 0000-0002-6048-8541 |
| VERIFIED | Yes |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 7 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Application of contrast-enhanced ultrasound to evaluate skeletal muscle perfusion in lower extremity arteriosclerotic obliterans of type 2 diabetes mellitus
To evaluate the value of contrast-enhanced ultrasound in evaluating skeletal muscle perfusion in Type 2 diabetic patients with lower extremity arteriosclerosis occlusion. 80 patients with type 2 diabetes were prospectively studied and divided into two groups: 40 patients with lower extremity arteriosclerosis obliterans(observation group)and 40 diabetic volunteers with normal lower extremity arteries(control group).All subjects were subjected to t…
Tocolytic Treatment for the Prevention of Preterm Birth from a Taiwanese Perspective
Preterm birth represents a great burden to the healthcare system, resulting in the consideration for the use of tocolytic therapy to provide a "better time" for delivery in order to buy time to accelerate fetal lung maturity, thereby minimizing prematurity-related morbidity and mortality. However, the benefits and potential side effects and risks of tocolytic treatment for preterm birth should be carefully balanced. Although many countries and so…
Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with Figo IIIC Serous-Type Tubo-Ovarian Cancer
The use of weekly chemotherapy for the treatment of patients with advanced-stage serous-type epithelial Tubo-ovarian cancer (ETOC), and primary peritoneal serous carcinoma (PPSC) is acceptable as the front-line postoperative chemotherapy after primary cytoreductive surgery (PCS). The main component of dose-dense chemotherapy is weekly paclitaxel (80 mg/m 2 ), but it would be interesting to know what is the difference between combination of triwee…
Functional Gene Clusters in Global Pathogenesis of Clear Cell Carcinoma of the Ovary Discovered by Integrated Analysis of Transcriptomes
Clear cell carcinoma of the ovary (ovarian clear cell carcinoma (OCCC)) is one epithelial ovarian carcinoma that is known to have a poor prognosis and a tendency for being refractory to treatment due to unclear pathogenesis. Published investigations of OCCC have mainly focused only on individual genes and lack of systematic integrated research to analyze the pathogenesis of OCCC in a genome-wide perspective. Thus, we conducted an integrated analy…
Radical Hysterectomy After Neoadjuvant Chemotherapy for Locally Bulky-Size Cervical Cancer
Radical hysterectomy (RH) is the standard treatment for early stage cervical cancer, but the surgical approach for locally bulky-size cervical cancer (LBS-CC) is still unclear. We retrospectively compared the outcomes of women with LBS-CC treated with neoadjuvant chemotherapy (NACT) and subsequent RH between the robotic (R-RH) and abdominal approaches (A-RH). Between 2012 and 2014, 39 women with LBS-CC FIGO (International Federation of Gynecology…
Weekly Dose-Dense Paclitaxel and Triweekly Low-Dose Cisplatin
A combination of cytoreductive surgery, either primary (PCS) or interval (ICS), and chemotherapy with a platinum-paclitaxel regimen is the well-accepted treatment for advanced-stage epithelial ovarian cancer (EOC), fallopian tube cancer (FTC), and primary peritoneal serous carcinoma (PPSC), but it is still uncertain whether a combination of dose-dense weekly paclitaxel and low-dose triweekly cisplatin is useful in the management of these patients…
Pattern of Ambulatory Care Visits to Obstetrician-Gynecologists in Taiwan
Although obstetrician-gynecologists (OB-GYNs) are the main actors in the provision of health care to women, their practice patterns have rarely been analyzed. The current study investigated the nationwide ambulatory visits to OB-GYNs in Taiwan using the National Health Insurance Research Database. From the 1/500 sampling datasets indicating 619,760 ambulatory visits in 2012, it was found that 5.8% (n = 35,697) of the visits were made to OB-GYNs. …
No prominent works on this page.
Pattern of Ambulatory Care Visits to Obstetrician-Gynecologists in Taiwan
Although obstetrician-gynecologists (OB-GYNs) are the main actors in the provision of health care to women, their practice patterns have rarely been analyzed. The current study investigated the nationwide ambulatory visits to OB-GYNs in Taiwan using the National Health Insurance Research Database. From the 1/500 sampling datasets indicating 619,760 ambulatory visits in 2012, it was found that 5.8% (n = 35,697) of the visits were made to OB-GYNs. …
Radical Hysterectomy After Neoadjuvant Chemotherapy for Locally Bulky-Size Cervical Cancer
Radical hysterectomy (RH) is the standard treatment for early stage cervical cancer, but the surgical approach for locally bulky-size cervical cancer (LBS-CC) is still unclear. We retrospectively compared the outcomes of women with LBS-CC treated with neoadjuvant chemotherapy (NACT) and subsequent RH between the robotic (R-RH) and abdominal approaches (A-RH). Between 2012 and 2014, 39 women with LBS-CC FIGO (International Federation of Gynecology…
Weekly Dose-Dense Paclitaxel and Triweekly Low-Dose Cisplatin
A combination of cytoreductive surgery, either primary (PCS) or interval (ICS), and chemotherapy with a platinum-paclitaxel regimen is the well-accepted treatment for advanced-stage epithelial ovarian cancer (EOC), fallopian tube cancer (FTC), and primary peritoneal serous carcinoma (PPSC), but it is still uncertain whether a combination of dose-dense weekly paclitaxel and low-dose triweekly cisplatin is useful in the management of these patients…
Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with Figo IIIC Serous-Type Tubo-Ovarian Cancer
The use of weekly chemotherapy for the treatment of patients with advanced-stage serous-type epithelial Tubo-ovarian cancer (ETOC), and primary peritoneal serous carcinoma (PPSC) is acceptable as the front-line postoperative chemotherapy after primary cytoreductive surgery (PCS). The main component of dose-dense chemotherapy is weekly paclitaxel (80 mg/m 2 ), but it would be interesting to know what is the difference between combination of triwee…
Functional Gene Clusters in Global Pathogenesis of Clear Cell Carcinoma of the Ovary Discovered by Integrated Analysis of Transcriptomes
Clear cell carcinoma of the ovary (ovarian clear cell carcinoma (OCCC)) is one epithelial ovarian carcinoma that is known to have a poor prognosis and a tendency for being refractory to treatment due to unclear pathogenesis. Published investigations of OCCC have mainly focused only on individual genes and lack of systematic integrated research to analyze the pathogenesis of OCCC in a genome-wide perspective. Thus, we conducted an integrated analy…
Tocolytic Treatment for the Prevention of Preterm Birth from a Taiwanese Perspective
Preterm birth represents a great burden to the healthcare system, resulting in the consideration for the use of tocolytic therapy to provide a "better time" for delivery in order to buy time to accelerate fetal lung maturity, thereby minimizing prematurity-related morbidity and mortality. However, the benefits and potential side effects and risks of tocolytic treatment for preterm birth should be carefully balanced. Although many countries and so…
Application of contrast-enhanced ultrasound to evaluate skeletal muscle perfusion in lower extremity arteriosclerotic obliterans of type 2 diabetes mellitus
To evaluate the value of contrast-enhanced ultrasound in evaluating skeletal muscle perfusion in Type 2 diabetic patients with lower extremity arteriosclerosis occlusion. 80 patients with type 2 diabetes were prospectively studied and divided into two groups: 40 patients with lower extremity arteriosclerosis obliterans(observation group)and 40 diabetic volunteers with normal lower extremity arteries(control group).All subjects were subjected to t…
Medicine (6 works) · Internal Medicine (5 works) · Ovarian cancer diagnosis and treatment (4 works) · Cancer (3 works) · Chemotherapy (3 works) · Endometrial and Cervical Cancer Treatments (3 works) · Oncology (3 works) · Cisplatin (2 works) · Gynecology (2 works) · Intraperitoneal and Appendiceal Malignancies (2 works)